223P Real-world treatment efficacy of ribociclib or palbociclib plus fulvestrant in hormone receptor-positive/HER2-negative metastatic breast cancer: Turkish Oncology Group (TOG) study

Kahraman S., Erul E., Gumusay O., Guven D., Aksoy S., Basaran G., ...More

ESMO OPEN, vol.9, no.Volume 9 - Issue S4 - 2024, pp.31-32, 2024 (SCI-Expanded)

  • Publication Type: Article / Article
  • Volume: 9 Issue: Volume 9 - Issue S4 - 2024
  • Publication Date: 2024
  • Doi Number: 10.1016/j.esmoop.2024.103245
  • Journal Name: ESMO OPEN
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, Directory of Open Access Journals
  • Page Numbers: pp.31-32
  • Çukurova University Affiliated: Yes